{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:42:38Z","timestamp":1780458158102,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11064-023-03860-9","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T08:02:42Z","timestamp":1674460962000},"page":"1775-1782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Alpha-Pinene Alleviates Motor Activity in Animal Model of Huntington\u2019s Disease via Enhancing Antioxidant Capacity"],"prefix":"10.1007","volume":"48","author":[{"given":"Helia","family":"Rahmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Raman","family":"Moloudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paria","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kambiz","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmael","family":"Izadpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"3860_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25:24\u201334","journal-title":"Eur J Neurol"},{"key":"3860_CR2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000443738","volume":"46","author":"MD Rawlins","year":"2016","unstructured":"Rawlins MD, Wexler NS, Wexler AR, Tabrizi SJ, Douglas I, Evans SJ, Smeeth L (2016) The prevalence of Huntington\u2019s disease. Neuroepidemiology 46:144\u2013153","journal-title":"Neuroepidemiology"},{"key":"3860_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/cge.12574","volume":"89","author":"F Squitieri","year":"2016","unstructured":"Squitieri F, Griguoli A, Capelli G, Porcellini A, D\u2019alessio B (2016) Epidemiology of Huntington disease: first post-HTT gene analysis of prevalence in Italy. Clin Genet 89:367\u2013370","journal-title":"Clin Genet"},{"key":"3860_CR4","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 90:905\u2013981","journal-title":"Physiol Rev"},{"key":"3860_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","volume":"59","author":"E Brouillet","year":"1999","unstructured":"Brouillet E, Cond\u00e9 F, Beal M, Hantraye P (1999) Replicating Huntington\u2019s disease phenotype in experimental animals. Prog Neurobiol 59:427\u2013468","journal-title":"Prog Neurobiol"},{"key":"3860_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrn3570","volume":"14","author":"MA Pouladi","year":"2013","unstructured":"Pouladi MA, Morton AJ, Hayden MR (2013) Choosing an animal model for the study of Huntington\u2019s disease. Nat Rev Neurosci 14:708\u2013721","journal-title":"Nat Rev Neurosci"},{"key":"3860_CR7","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","volume":"95","author":"E Brouillet","year":"2005","unstructured":"Brouillet E, Jacquard C, Bizat N, Blum D (2005) 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington\u2019s disease. J Neurochem 95:1521\u20131540","journal-title":"J Neurochem"},{"key":"3860_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/ilar.48.4.356","volume":"48","author":"S Ramaswamy","year":"2007","unstructured":"Ramaswamy S, McBride JL, Kordower JH (2007) Animal models of Huntington\u2019s disease. ILAR J 48:356\u2013373","journal-title":"ILAR J"},{"key":"3860_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83\u201398","journal-title":"Lancet Neurol"},{"key":"3860_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fnmol.2019.00068","volume":"12","author":"BD Paul","year":"2019","unstructured":"Paul BD, Snyder SH (2019) Impaired redox signaling in Huntington\u2019s disease: therapeutic implications. Front Mol Neurosci 12:68","journal-title":"Front Mol Neurosci"},{"key":"3860_CR11","doi-asserted-by":"publisher","first-page":"112857","DOI":"10.1016\/j.phytochem.2021.112857","volume":"190","author":"M Allenspach","year":"2021","unstructured":"Allenspach M, Steuer C (2021) \u03b1-Pinene: a never-ending story. Phytochemistry 190:112857","journal-title":"Phytochemistry"},{"key":"3860_CR12","first-page":"363","volume":"3","author":"A Him","year":"2008","unstructured":"Him A, Ozbek H, Turel I, Oner AC (2008) Antinociceptive activity of alpha-pinene and fenchone. Pharmacologyonline 3:363\u2013369","journal-title":"Pharmacologyonline"},{"key":"3860_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1515\/znc-2014-4135","volume":"71","author":"M Porres-Mart\u00ednez","year":"2016","unstructured":"Porres-Mart\u00ednez M, Gonz\u00e1lez-Burgos E, Carretero ME, G\u00f3mez-Serranillos MP (2016) In vitro neuroprotective potential of the monoterpenes \u03b1-pinene and 1, 8-cineole against H2O2-induced oxidative stress in PC12 cells. Z Naturforsch C 71:191\u2013199","journal-title":"Z Naturforsch C"},{"key":"3860_CR14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1142\/S0192415X15500457","volume":"43","author":"D-S Kim","year":"2015","unstructured":"Kim D-S, Lee H-J, Jeon Y-D, Han Y-H, Kee J-Y, Kim H-J, Shin H-J, Kang J, Lee BS, Kim S-H (2015) Alpha-pinene exhibits anti-inflammatory activity through the suppression of MAPKs and the NF-\u03baB pathway in mouse peritoneal macrophages. Am J Chinese Med 43:731\u2013742","journal-title":"Am J Chinese Med"},{"key":"3860_CR15","first-page":"53","volume":"4","author":"S Goudarzi","year":"2017","unstructured":"Goudarzi S, Rafieirad M (2017) Evaluating the effect of \u03b1-pinene on motor activity, avoidance memory and lipid peroxidation in animal model of Parkinson disease in adult male rats. Res j pharmacogn 4:53\u201363","journal-title":"Res j pharmacogn"},{"key":"3860_CR16","first-page":"1","volume":"2017","author":"G-Y Lee","year":"2017","unstructured":"Lee G-Y, Lee C, Park GH, Jang J-H (2017) Amelioration of scopolamine-induced learning and memory impairment by \u03b1-Pinene in C57BL\/6 mice. Evid Based Complementary Altern Med 2017:1\u20139","journal-title":"Evid Based Complementary Altern Med"},{"key":"3860_CR17","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s11064-021-03271-8","volume":"46","author":"A Fotoohi","year":"2021","unstructured":"Fotoohi A, Moloudi MR, Hosseini S, Hassanzadeh K, Feligioni M, Izadpanah E (2021) A novel pharmacological protective role for Safranal in an animal model of Huntington\u2019s Disease. Neurochem Res 46:1372\u20131379","journal-title":"Neurochem Res"},{"key":"3860_CR18","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1080\/13880209.2017.1285945","volume":"55","author":"J Malik","year":"2017","unstructured":"Malik J, Karan M, Dogra R (2017) Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism. Pharm Biol 55:980\u2013990","journal-title":"Pharm Biol"},{"key":"3860_CR19","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.lfs.2012.08.035","volume":"91","author":"G-S Bae","year":"2012","unstructured":"Bae G-S, Park K-C, Choi SB, Jo I-J, Choi M-O, Hong S-H, Song K, Song H-J, Park S-J (2012) Protective effects of alpha-pinene in mice with cerulein-induced acute pancreatitis. Life Sci 91:866\u2013871","journal-title":"Life Sci"},{"key":"3860_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.pnpbp.2008.10.013","volume":"33","author":"P Kumar","year":"2009","unstructured":"Kumar P, Kumar A (2009) Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain. Prog Neuro-Psychopharmacology Biol 33:100\u2013108","journal-title":"Prog Neuro-Psychopharmacology Biol"},{"key":"3860_CR21","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.toxrep.2015.08.004","volume":"2","author":"N Kaur","year":"2015","unstructured":"Kaur N, Jamwal S, Deshmukh R, Gauttam V, Kumar P (2015) Beneficial effect of rice bran extract against 3-nitropropionic acid induced experimental Huntington\u2019s disease in rats. Toxicol Rep 2:1222\u20131232","journal-title":"Toxicol Rep"},{"key":"3860_CR22","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/molecules15020878","volume":"15","author":"I T\u00fanez","year":"2010","unstructured":"T\u00fanez I, Tasset I, P\u00e9rez-De La Cruz V, Santamar\u00eda A (2010) 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington\u2019s disease: past, present and future. Molecules 15:878\u2013916","journal-title":"Molecules"},{"key":"3860_CR23","first-page":"1934578X1501000","volume":"10","author":"H Kasuya","year":"2015","unstructured":"Kasuya H, Iida S, Ono K, Satou T, Koike K (2015) Intracerebral distribution of \u03b1-pinene and the anxiolytic-like effect in mice following inhaled administration of essential oil from Chamaecyparis obtusa. Nat Prod Commun 10:1934578X1501000841","journal-title":"Nat Prod Commun"},{"key":"3860_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jtcme.2019.01.003","volume":"10","author":"S Abbasi-Maleki","year":"2020","unstructured":"Abbasi-Maleki S, Kadkhoda Z, Taghizad-Farid R (2020) The antidepressant-like effects of Origanum majorana essential oil on mice through monoaminergic modulation using the forced swimming test. J Tradit Complement Med 10:327\u2013335","journal-title":"J Tradit Complement Med"},{"key":"3860_CR25","first-page":"253","volume":"24","author":"S Saeedipour","year":"2020","unstructured":"Saeedipour S, Rafieirad M (2020) Anti-anxiety effect of alpha-pinene in comparison with diazepam in adult male rats. KAUMS J (FEYZ) 24:253\u2013245","journal-title":"KAUMS J (FEYZ)"},{"key":"3860_CR26","first-page":"29","volume":"3","author":"M Zamyad","year":"2016","unstructured":"Zamyad M, Abasnejad M, Esmaeili-Mahani S, Mostafavi A (2016) Alpha-pinene as the main component of Ducrosia anethifolia (Boiss) essential oil is responsible for its effect on locomotor activity in rats. Avicenna J neuropsychophysiology 3:29\u201334","journal-title":"Avicenna J neuropsychophysiology"},{"key":"3860_CR27","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/ng.2732","volume":"45","author":"RP Mason","year":"2013","unstructured":"Mason RP, Casu M, Butler N, Breda C, Campesan S, Clapp J, Green EW, Dhulkhed D, Kyriacou CP, Giorgini F (2013) Glutathione peroxidase activity is neuroprotective in models of Huntington\u2019s disease. Nat Genet 45:1249\u20131254","journal-title":"Nat Genet"},{"key":"3860_CR28","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s11064-006-9110-2","volume":"31","author":"P del Hoyo","year":"2006","unstructured":"del Hoyo P, Garc\u00eda-Redondo A, de Bustos F, Molina JA, Sayed Y, Alonso-Navarro H, Caballero L, Arenas J, Jim\u00e9nez-Jim\u00e9nez FJ (2006) Oxidative stress in skin fibroblasts cultures of patients with Huntington\u2019s disease. Neurochem Res 31:1103\u20131109","journal-title":"Neurochem Res"},{"key":"3860_CR29","doi-asserted-by":"publisher","first-page":"104977","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104977","volume":"29","author":"M Khoshnazar","year":"2020","unstructured":"Khoshnazar M, Parvardeh S, Bigdeli MR (2020) Alpha-pinene exerts neuroprotective effects via anti-inflammatory and anti-apoptotic mechanisms in a rat model of focal cerebral ischemia-reperfusion. J Stroke Cerebrovasc Dis 29:104977","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"3860_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ptr.5224","volume":"29","author":"H Kasuya","year":"2015","unstructured":"Kasuya H, Okada N, Kubohara M, Satou T, Masuo Y, Koike K (2015) Expression of BDNF and TH mRNA in the brain following inhaled administration of \u03b1-pinene. Phytother Res 29:43\u201347","journal-title":"Phytother Res"},{"key":"3860_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.7897\/2230-8407.110662","volume":"11","author":"R Prabhu","year":"2020","unstructured":"Prabhu R, Pradeep S, Lalit P (2020) Protective activity of alpha-pinene and trans-anethole against 3-nitro propionic acid induced neurotoxicity in animal model of Huntington\u2019s disease. Int Res J Pharm 11:32\u201338","journal-title":"Int Res J Pharm"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-03860-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-023-03860-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-03860-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T23:43:44Z","timestamp":1682034224000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-023-03860-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3860"],"URL":"https:\/\/doi.org\/10.1007\/s11064-023-03860-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1781984\/v1","asserted-by":"object"}]},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"21 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}